These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management of hypertensive crises. Feldstein C Am J Ther; 2007; 14(2):135-9. PubMed ID: 17414580 [TBL] [Abstract][Full Text] [Related]
6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
8. [Are all antihypertensive drugs renoprotective?]. Wolf S; Risler T Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950 [TBL] [Abstract][Full Text] [Related]
9. Drug therapy of hypertensive crises. Stumpf JL Clin Pharm; 1988 Aug; 7(8):582-91. PubMed ID: 3048849 [TBL] [Abstract][Full Text] [Related]
10. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C; Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [TBL] [Abstract][Full Text] [Related]
11. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?]. Horký K Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167 [TBL] [Abstract][Full Text] [Related]
12. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
13. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats. Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768 [TBL] [Abstract][Full Text] [Related]
14. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
15. [Retrospective studies and prospects of therapy for hypertension]. Maisch B; Brilla C; Kruse T; Noll B; Bethge C Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [TBL] [Abstract][Full Text] [Related]
16. The diagnosis and treatment of hypertensive crises. Varon J Postgrad Med; 2009 Jan; 121(1):5-13. PubMed ID: 19179809 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function. Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536 [TBL] [Abstract][Full Text] [Related]
18. [Hypertensive crisis: when and how to treat?]. Leeman M Rev Med Brux; 2004 Apr; 25(2):73-8. PubMed ID: 15157059 [TBL] [Abstract][Full Text] [Related]
19. [Hypertensive crisis and its treatment]. de Châtel R Z Gesamte Inn Med; 1980 Oct; 35(19):suppl 106-9. PubMed ID: 7210750 [TBL] [Abstract][Full Text] [Related]
20. Hypertensive crisis. Rodriguez MA; Kumar SK; De Caro M Cardiol Rev; 2010; 18(2):102-7. PubMed ID: 20160537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]